AU2012101841A4 - Compositions comprising cetilistat - Google Patents

Compositions comprising cetilistat Download PDF

Info

Publication number
AU2012101841A4
AU2012101841A4 AU2012101841A AU2012101841A AU2012101841A4 AU 2012101841 A4 AU2012101841 A4 AU 2012101841A4 AU 2012101841 A AU2012101841 A AU 2012101841A AU 2012101841 A AU2012101841 A AU 2012101841A AU 2012101841 A4 AU2012101841 A4 AU 2012101841A4
Authority
AU
Australia
Prior art keywords
cetilistat
composition
capsule
formulation
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012101841A
Other languages
English (en)
Inventor
John Robert Bloor
Christopher Robert Dunk
Richard Michael John Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine BV
Original Assignee
Norgine BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1122213.0A external-priority patent/GB201122213D0/en
Priority claimed from GBGB1203082.1A external-priority patent/GB201203082D0/en
Application filed by Norgine BV filed Critical Norgine BV
Application granted granted Critical
Publication of AU2012101841A4 publication Critical patent/AU2012101841A4/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Logic Circuits (AREA)
  • Manipulation Of Pulses (AREA)
AU2012101841A 2011-12-23 2012-12-17 Compositions comprising cetilistat Ceased AU2012101841A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1122213.0 2011-12-23
GBGB1122213.0A GB201122213D0 (en) 2011-12-23 2011-12-23 Compositions
GB1203082.1 2012-02-22
GBGB1203082.1A GB201203082D0 (en) 2012-02-22 2012-02-22 Compositions

Publications (1)

Publication Number Publication Date
AU2012101841A4 true AU2012101841A4 (en) 2013-01-17

Family

ID=47560448

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012101841A Ceased AU2012101841A4 (en) 2011-12-23 2012-12-17 Compositions comprising cetilistat

Country Status (8)

Country Link
AU (1) AU2012101841A4 (es)
DK (1) DK201200198Y4 (es)
ES (1) ES2417408B1 (es)
FI (1) FI10194U1 (es)
FR (1) FR2984745B3 (es)
IE (1) IES20120556A2 (es)
IT (1) ITTO20121118A1 (es)
NL (1) NL2009995C2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation
JP2010254623A (ja) * 2009-04-24 2010-11-11 Takeda Chem Ind Ltd ベンゾオキサジノン化合物の結晶

Also Published As

Publication number Publication date
FR2984745B3 (fr) 2017-12-22
NL2009995C2 (en) 2013-09-18
IES86183B2 (en) 2013-05-08
DK201200198U1 (en) 2013-04-12
NL2009995A (en) 2013-06-26
FR2984745A3 (fr) 2013-06-28
DK201200198Y4 (da) 2018-09-17
FI10194U1 (fi) 2013-08-20
ES2417408R1 (es) 2013-10-15
ITTO20121118A1 (it) 2013-06-24
ES2417408B1 (es) 2014-11-26
ES2417408A2 (es) 2013-08-07
IES20120556A2 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
EP1898904B1 (en) Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
CA2821196C (en) Gastric and colonic formulations and methods for making and using them
US20070087048A1 (en) Oral dosage combination pharmaceutical packaging
KR20150046310A (ko) 완화제 조성물 및 변비 및 관련 위장관 질병 및 증상 치료를 위한 방법
RU2640561C2 (ru) Повышение биодоступности лекарственных средств при терапии налтрексоном
EP1933815A2 (en) Pharmaceutical packaging of an oral dosage combination
US9060979B2 (en) Antidepressant
US20080038336A1 (en) Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent
AU2012101841A4 (en) Compositions comprising cetilistat
DE202012104963U1 (de) Cetilistat aufweisende Zusammensetzungen
US20150086621A1 (en) Dietary fiber compositions for the treatment of metabolic disease
WO2013092786A1 (en) Compositions comprising cetilistat
IES86183Y1 (en) Compositions comprising cetilistat
IE20120556U1 (en) Compositions comprising cetilistat
HUE026230T2 (en) Pharmaceutical composition containing citrate and bicarbonate salts and use in the treatment of cystinuria
WO2010104175A1 (ja) 経口用組成物
US20080107715A1 (en) Pharmaceutical containing food compositions and uses thereof
US20150104539A1 (en) Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications
WO2017221886A1 (ja) 腸内環境改善剤
RU2552926C1 (ru) Фармацевтическая комбинация для лечения и/или предупреждения нарушений, связанных с избыточным весом и/или ожирением, и способ лечения на ее основе
CN106955357B (zh) 一种用于宠物减肥的复方奥利司他组合物制剂及其应用
CN106822133A (zh) 一种治疗急性腹泻的西药组合物
EP2016946B1 (en) Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent
AT13775U1 (de) Pharmazeutische Zusammensetzung
EP1941910A1 (en) Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK21 Patent ceased section 101c(b)/section 143a(c)/reg. 9a.4 - examination under section 101b had not been carried out within the period prescribed